1. Covering the Cover Gastroenterology
Anson W. Lowe, Richard H. Moseley 
Gastroenterology 
Volume 145, Issue 3, Pages (September 2013)
DOI: /j.gastro
Copyright © 2013 AGA Institute Terms and Conditions

2. Figure 1
Effect of the sweetening agent. (A) Independently of carbonation, sucrose increased (yellow-red) activity compared with As-Ac in Amy and As-Ac increased activity in AI. (B) Differential brain activity for sucrose versus As-Ac was more evident without than with CO2 and diffusely in favor of sucrose (left OTC, MTC, and OFC). (C) CO2 reduced differential brain activity, which was higher for As-Ac in AI, OTC, ITC, and OFC. Amy, amygdala; AI, anterior insula; ITC, inferior temporal cortex; MTC, mesial-temporal cortex; OFC, orbitofrontal cortex; OTC, occipitotemporal cortex.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions

3. Figure 2
Propensity for organ-specific metastasis of oncospheres derived from nonmetastasizing tumor (CRC108), or metastasis from the liver (CRC108-LM) or lung (CRC108-PM).
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions

4. Figure 3
Effects of ONO1301, Beraprost, Ozagrel, and Telaprevir on the expansion of bbHCV-infected urokinase plasminogen activator/severe combined immunodeficiency mice bearing human hepatocytes. Data are presented as means ± SD for 6 (control, diamonds), 4 (ONO1301, squares; Ozagrel, crosses; Telaprevir, asterisk), and 3 (Beraprost, triangles) samples. *Differs from control, P < .05.
Gastroenterology  , DOI: ( /j.gastro )
Copyright © 2013 AGA Institute Terms and Conditions